| HOME >> BIOLOGY >> TECHNOLOGY |
severity, possibly re-setting the immune system and slowing the
destruction of their insulin-producing cells.
ABOUT THE MEETINGS
The Type 1 Diabetes TrialNet Study Group
This group of type 1 diabetes experts will meet November 12-14 to discuss current and planned research around type 1 diabetes. Researchers at more than 150 medical centers in the U.S., Canada, Europe and Australia have joined this global network dedicated to study the prevention, early detection and treatment of type 1 diabetes. These centers are offering free screenings for relatives of people with type 1 diabetes, as well as clinical trials in prevention, early detection and early onset. Type 1 Diabetes TrialNet is supported by the National Institutes of Health (NIH), Juvenile Diabetes Research Foundation International, and the American Diabetes Association. To learn more about Type 1 Diabetes TrialNet, visit http://www.DiabetesTrialNet.org
The 9th International Congress of the Immunology of Diabetes Society (IDS) and American Diabetes Association (ADA) Research Symposium
International researchers will meet November 14-18 to discuss the latest science and theories in type 1 diabetes research. IDS is an international collaboration created to advance research in the etiology, pathogenesis, prevention and cure of type 1 diabetes. A key area of focus is clinical trials to alter the type 1 diabetes disease process, eventually leading to prevention of this disease. ADA's mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
TO REGISTER FOR THE MEDIA TELECONFERENCE:
Please contact:
Sarah Bakka
301.348.1685
| SOURCE TrialNet Copyright©2007 PR Newswire. All rights reserved |